China Life Insurance Company Limited (LFC) : Traders are bullish on China Life Insurance Company Limited (LFC) as it has outperformed the S&P 500 by a wide margin of 4.66% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.03%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 4.08% in the last 1 week, and is up 5.74% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 4.83% and the 50-Day Moving Average is 8.63%. China Life Insurance Company Limited (NYSE:LFC): stock turned positive on Friday. Though the stock opened at $11.9, the bulls momentum made the stock top out at $12.03 level for the day. The stock recorded a low of $11.9 and closed the trading day at $11.98, in the green by 1.27%. The total traded volume for the day was 631,873. The stock had closed at $11.83 in the previous days trading.
Institutional Investors own 0.29% of China Life Insurance Company Limited shares. Also, UBS upgrades its view on China Life Insurance Company Limited (NYSE:LFC) according to the research report released by the firm to its investors. The shares have now been rated Buy by the stock experts at the ratings house. Earlier, the shares had a rating of Neutral. The rating by the firm was issued on July 18, 2016.
China Life Insurance Company Limited is a life insurance company. The Company and its subsidiaries are principally engaged in providing individual and group life insurance, annuity products, and accident and health insurance in China. It operates in five operating segments: Individual life insurance business, which relates to the sale of long-term insurance contracts and universal contracts; Group life insurance business, which relates to the sale of long-term insurance contracts and investment contracts; Short-term insurance business, which relates primarily to the sale of short-term insurance contracts; Supplementary major medical insurance business, which relates primarily to the sale of supplementary major medical insurance contracts, and Other businesses.